A phase 2 trial of antisense nucleotide to PKC-alpha (LY900003, ISIS 3521) [aprinocarsen] plus gemcitabine and carboplatin in patients with advanced, previously untreated non-small cell lung cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Aprinocarsen (Primary) ; Carboplatin (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Aug 2006 Status change
- 10 Sep 2005 New trial record.